Resources

9 Resources for

greenbackd and healthcare

Subscribe to this listing via:
RSS
Email

BNET Resources

Avigen Could Yield Considerably More than Its Net Cash Value: Greenbackd submits: Avigen Inc AVGN has been granted a United States Patent for the treatment of neuropathic pain with its AV411 ibudilast compound. We started following AVGN in December last year see archived posts here because it was a net cash stock (i.e. it was trading at...; Tags: Biotech, Healthcare, Greenbackd, Avigen Inc.; External links 2009-05-22
Avigen Update: Company Could Yield More than Its Net Cash Value: Greenbackd submits: Avigen Inc AVGN has filed its 10Q for the period ended March 31, 2009. We started following AVGN in December last year see archived posts here because it was a net cash stock (i.e. it was trading at less than the value of its cash...; Tags: Healthcare, Greenbackd, Avigen Inc.; External links 2009-05-14
VaxGen Nominates Director Candidates, Clarifies Rights to AIDS Vaccine: Greenbackd submits: It’s been a big week for VaxGen Inc (VXGN.OB). On Tuesday last week the “VaxGen Full Value Committee” nominated five director candidates to the board. Then on Thursday BizJournals.com reported that VXGN’s “failed AIDS vaccine” was “successful in a new trial that combined it with another failed...; Tags: Healthcare, Biotech, Greenbackd; External links 2009-09-30
Cadus Corp: Classic Value Trap or Worth a Second Look?: Greenbackd submits: Cadus Corporation (KDUS.OB) is an interesting play, but not without hairs on it. First, the good news: It’s trading at a discount to net cash with Carl Icahn disclosing an activist holding in 2002, and Moab Capital Partners disclosing an activist holding more recently. At its $1.51...; Tags: Healthcare, Greenbackd; External links 2009-09-29
Capstone Therapeutics: Q2 Update: Greenbackd submits: OrthoLogic Corporation CAPS has filed its 10Q for the quarter ended June 30, 2008. We’ve been following CAPS see our post archive here because it trades below its net cash value and Biotechnology Value Fund (BVF) has a 13.42% holding. It’s an unusual holding for...; Tags: Biotech, Healthcare, Greenbackd, Caprius Inc.; External links 2009-08-13

Digirad Still Showing Strong Potential: Greenbackd submits: Digirad Corporation (NASDAQ:DRAD) has filed its 10Q for the quarter ended June 30, 2009. We started following DRAD see our post archive here because it was an undervalued asset play with a plan to sell assets and buy back its stock. The stock is up...; Tags: Healthcare, Greenbackd, Digirad Corp.; External links 2009-07-24
Tang Capital Partners' Proxy Statement for Vanda Pharmaceuticals Calls for Liquidation: Greenbackd submits: Tang Capital Partners has filed a preliminary proxy statement for the Vanda Pharmaceuticals (Nasdaq: VNDA) 2009 Annual Meeting of Stockholders urging stockholders to support Tang Capital Partners’ slate of two director nominees, Kevin C. Tang and Andrew D. Levin, M.D., Ph.D. We’ve been following VNDA...; Tags: Healthcare, Greenbackd, Vanda Pharmaceuticals Inc.; External links 2009-04-09
Digirad Planning to Sell Assests and Buy Back Stock: Greenbackd submits: Digirad Corporation DRAD is a tiny undervalued asset play with a plan to sell assets and buy back its stock. At its $0.88 close on Friday, the company has a market capitlization of $16.7M. We estimate the liquidation value to be around 76% higher at $29.3M or...; Tags: Healthcare, Greenbackd, Digirad Corp.; External links 2009-03-09
HRT Watch: Plan to Buy Back Stock Good News for Shareholders: Greenbackd submits: Arrhythmia Research Technology Inc HRT is a tiny but profitable net net stock with a plan to buy back stock. At its $2.25 close yesterday the company has a market capitalization of just $6.1M. We estimate its pre-buy back liquidation value to be more than 100% higher...; Tags: Healthcare, Greenbackd, Arrhythmia Research Technology Inc.; External links 2009-01-14